Deadline next week: revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit - rvnc

San diego, california--(newsfile corp. - february 3, 2022) -  robbins geller rudman & dowd llp announces that purchasers of revance therapeutics, inc. (nasdaq: rvnc) securities between november 25, 2019 and october 11, 2021, inclusive ("class period") have until tuesday, february 8, 2022, to seek appointment as lead plaintiff in aramic llc v. revance therapeutics, inc., no. 21-cv-09585 (n.d. cal.). commenced on december 10, 2021, the revance therapeutics class action lawsuit charges revance therapeutics along...
RVNC Ratings Summary
RVNC Quant Ranking